Insys Therapeutics, Inc. (NASDAQ:INSY) Basic Net EPS Stands At $0.82

0

Insys Therapeutics, Inc. (NASDAQ:INSY) had an annual basic consolidated EPS of $0.8168 for the period ended 2015-12-31. For the quarter ended 2015-12-31 which was on quarterly basis, the basic consolidated EPS reading was $0.8168.

EPS from continuing operations

Insys Therapeutics, Inc. (NASDAQ:INSY) reported $0.8168 as the basic EPS from continuing operations for the annual period ended 2015-12-31. Quarterly basic EPS from continuing operations stood at $0.8168 for the three-month period ended 2015-12-31.

EPS contribution from parent

From its parent company, Insys Therapeutics, Inc. (NASDAQ:INSY) received basic EPS of $0.8168 for the annual period ended 2015-12-31. EPS contribution from the parent company was $0.8168 which was on quarterly basis for the period ended 2015-12-31.

Basic net EPS

A basic net EPS of $0.82 was reported by Insys Therapeutics, Inc. (NASDAQ:INSY) for the annual period ended 2015-12-31. For the three-month period ended 2015-12-31 which was on a quarterly basis, the company’s basic net EPS stood at $0.82.

Consolidated diluted EPS

For the period ended 2015-12-31, $0.7724 was reported as the annual consolidated diluted EPS reading. Consolidated diluted EPS was $0.7724 for the quarter ended 2015-12-31.

Basic diluted EPS

Diluted EPS reading from continuing operation was $0.7724 which was on annual basis but for the period ended 2015-12-31. From continuing operations, Diluted EPS was $0.7724 for the quarter ended 2015-12-31.

Net diluted EPS

Net diluted EPS reading was $0.77 for the annual period ended 2015-12-31 while the net diluted EPS for the quarterly period ended 2015-12-31 stood at $0.77.

Diluted EPS from parent

Diluted EPS of $0.7724 was received by Insys Therapeutics, Inc. (NASDAQ:INSY) from its parent company which was for the annual period ended 2015-12-31. For the quarter ended 2015-12-31, diluted EPS contribution from the parent was $0.7724 on quarterly basis. For the annual period ended 2015-12-31, $0.82 was posted by Insys Therapeutics, Inc. (NASDAQ:INSY) as net basic EPS reading.

For the quarter ended 2015-12-31, basic net EPS of $0.82 was reported. The period ended 2015-12-31 had annual average basic shares outstanding of 71.593. But it was 71.593 for the quarter ended 2015-12-31. 75.708 and 75.708 were the diluted shares outstanding for the fiscal year ended is 2015-12-31 respectively.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 7 times, 1 visits today)